- Report
- April 2025
- 50 Pages
Global
From €2534EUR$2,650USD£2,121GBP
- Report
- March 2024
- 397 Pages
Global
From €7601EUR$7,950USD£6,363GBP
- Report
- March 2018
- 17 Pages
Global
From €9561EUR$10,000USD£8,003GBP
Blonanserin is a drug used to treat mental disorders, such as schizophrenia and bipolar disorder. It is a second-generation antipsychotic, meaning it is a newer type of antipsychotic drug that is thought to have fewer side effects than first-generation antipsychotics. Blonanserin works by blocking certain receptors in the brain, which helps to reduce symptoms of mental disorders. It is available in tablet form and is usually taken once or twice a day.
The Blonanserin market is a growing one, with more and more people being diagnosed with mental disorders each year. It is a highly competitive market, with many different companies offering their own versions of the drug. Companies such as Otsuka Pharmaceutical, Dainippon Sumitomo Pharma, and Takeda Pharmaceutical are all major players in the Blonanserin market. Other companies such as Sunovion Pharmaceuticals, Lundbeck, and Intas Pharmaceuticals also offer their own versions of the drug. Show Less Read more